We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. MHCtools 1.5: Analysis of MHC Sequencing Data in R

    The genes of the major histocompatibility complex (MHC) play a vital role in the vertebrate immune system and have attracted considerable interest in...
    Jacob Roved in HLA Ty**
    Protocol 2024
  2. Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects

    The molecules of Major histocompatibility class I (MHC-I) load peptides and present them on the cell surface, which provided the immune system with...

    **angyu Wu, Tianhang Li, ... Rong Yang in Molecular Cancer
    Article Open access 02 December 2023
  3. Neoself Antigens Presented on MHC Class II Molecules in Autoimmune Diseases

    Major histocompatibility complex (MHC) class II molecules play a crucial role in immunity by presenting peptide antigens to helper T cells. Immune...
    Chapter 2024
  4. MHC II immunogenicity shapes the neoepitope landscape in human tumors

    Despite advances in predicting physical peptide-major histocompatibility complex I (pMHC I) binding, it remains challenging to identify functionally...

    Jeong Yeon Kim, Hongui Cha, ... Jung Kyoon Choi in Nature Genetics
    Article 09 January 2023
  5. Antiallergic Effects of Technologically Processed Antibodies to MHC II

    The risk of develo** anaphylactic reactions to medications introduces additional difficulties for effective pharmacotherapy. Using a model of...

    N. V. Petrova, S. A. Tarasov, ... V. V. Smirnov in Bulletin of Experimental Biology and Medicine
    Article 01 October 2023
  6. Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer

    Background

    In prostate cancer (PCa), well-established biomarkers such as MSI status, TMB high, and PDL1 expression serve as reliable indicators for...

    William Lautert-Dutra, Camila M. Melo, ... Jeremy A. Squire in Molecular Cytogenetics
    Article Open access 04 May 2024
  7. Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response

    The extent to which unconventional forms of antigen presentation drive T cell immunity is unknown. By convention, CD8 T cells recognize viral...

    Michael J. Hogan, Nikita Maheshwari, ... Laurence C. Eisenlohr in Nature Immunology
    Article 12 October 2023
  8. LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression

    Background

    LATS1/2 are frequently mutated and down-regulated in endometrial cancer (EC), but the contributions of LATS1/2 in EC progression remains...

    Qianlan Yang, Zehen Lv, ... ** Wan in Journal of Experimental & Clinical Cancer Research
    Article Open access 21 February 2024
  9. How to Predict Binding Specificity and Ligands for New MHC-II Alleles with MixMHC2pred

    MHC-II molecules are key mediators of antigen presentation in vertebrate species and bind to their ligands with high specificity. The very high...
    Julien Racle, David Gfeller in HLA Ty**
    Protocol 2024
  10. Modulation of MHC and MHC-Like Molecules by Varicella Zoster Virus

    Varicella zoster virus (VZV) is a medically important human herpesvirus that has co-evolved with the human host to become a highly successful and...
    Allison Abendroth, Barry Slobedman in Varicella-zoster Virus
    Chapter 2022
  11. Tumor-associated macrophage-derived exosomes LINC01592 induce the immune escape of esophageal cancer by decreasing MHC-I surface expression

    Background

    TAMs (tumor-associated macrophages) infiltration promotes the progression of esophageal cancer (EC). However, the underlying mechanisms...

    **nwei Qiao, Zaixing Cheng, ... **song Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 02 November 2023
  12. TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity

    Immune checkpoint therapies (ICT) for advanced solid tumors mark a new milestone in cancer therapy. Yet their efficacy is often limited by poor...

    Miriam Langguth, Eleftheria Maranou, ... Carlos R. Figueiredo in Genes & Immunity
    Article Open access 22 May 2024
  13. Pharmacologic inhibition of IL11/STAT3 signaling increases MHC-I expression and T cell infiltration

    Background

    Recent studies have discovered an emerging role of IL11 in various colitis-associated cancers, suggesting that IL11 mainly promotes tumor...

    Wenjun **ong, Yuehong Chen, ... Tingyu Mou in Journal of Translational Medicine
    Article Open access 26 June 2023
  14. Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy

    Background

    Proprotein convertase subtilisin/kexin type 9 (PCSK9), the last member of the proprotein convertase family, functions as a classic...

    Hanbing Wang, **n Zhang, ... Jia Wei in BMC Cancer
    Article Open access 10 April 2024
  15. Designing High Binding Affinity Peptides for MHC Class I Using MAM: An In Silico Approach

    The availability of extensive MHC-peptide binding data has boosted machine learning-based approaches for predicting binding affinity and identifying...
    Yu Wei Zhang in HLA Ty**
    Protocol 2024
  16. Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

    Background

    Although immune checkpoint blockade (ICB) therapy has proven to be extremely effective at managing certain cancers, its efficacy in...

    **Shan Zhong, Kohei Nakata, ... Masafumi Nakamura in Journal of Experimental & Clinical Cancer Research
    Article Open access 08 May 2024
  17. The minor chicken class I gene BF1 is deleted between short imperfect direct repeats in the B14 and typical B15 major histocompatibility complex (MHC) haplotypes

    The chicken major histocompatibility complex (MHC, also known as the BF-BL region of the B locus) is notably small and simple with few genes, most of...

    Nicolas I. E. Rocos, Felicity J. Coulter, ... Jim Kaufman in Immunogenetics
    Article Open access 05 July 2023
  18. Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population

    Purpose

    Major histocompatibility complex class II (MHC-II) deficiency is a rare inborn error of immunity (IEI). Impaired antigen presentation to...

    Mohadese Sadat Mousavi Khorshidi, Yoann Seeleuthner, ... Nima Parvaneh in Journal of Clinical Immunology
    Article 16 August 2023
  19. MHC class I links with severe pathogenicity in C57BL/6N mice infected with SARS-CoV-2/BMA8

    Background

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes non-symptomatic infection, mild influenza-like symptoms to...

    Tian Qin, Beilei Shen, ... Yuwei Gao in Virology Journal
    Article Open access 20 April 2023
  20. Patterns of evolution in MHC class II DQA and DQB exon 2 genes of Alpine mountain hares, Lepus timidus varronis, and sympatric and parapatric brown hares, L. europaeus, from Switzerland

    In natural populations, hybridization is known to occur between a wide range of species. However, its evolutionary significance is less clear. Genes...

    A. Awadi, H. Ben Slimen, ... F. Suchentrunk in Immunogenetics
    Article 20 December 2023
Did you find what you were looking for? Share feedback.